Table 5
Neuromotor outcome (cerebral palsy) and major impairment in survivors seen
| Outcome | Etamsylate (n = 133) | Placebo (n = 135) |
|---|---|---|
| There is no reduction in cerebral palsy in the etamsylate group. Multiple major impairment is a subset of the major impairment group. One child in the placebo group not seen but known to have a quadriplegia is not included. | ||
| IVH, Intraventricular haemorrhage. | ||
| Spastic quadriplegia | 4 | 7 |
| Spastic hemiplegia | 7 | 4 |
| Spastic diplegia | 3 | 2 |
| Spastic monoplegia | 1 | 0 |
| Ataxic | 1 | 0 |
| Hypotonic | 0 | 1 |
| Total with cerebral palsy | 16 | 14 |
| Major impairment | ||
| Boys | 12 | 11 |
| Girls | 6 | 11 |
| Total | 18 | 22 |
| Multiple major impairment | ||
| Boys | 3 | 4 |
| Girls | 1 | 7 |
| Total | 4 | 11 |
| Multiple major impairment and grade 2 or 3 IVH | 3 | 9 |
